《大行報告》富瑞下調人保(01339.HK)目標價至2.8元 降新華保險(01336.HK)評級至「持有」
富瑞發表評級報告指,多家內地保險公司公布了8月原保費收入,第三季保費收入因季節性因素影響,低於次季,惟部分公司顯示了其新業務價值呈穩定跡象。該行指,即使積極正面因素並沒有明顯增加,但財險(02328.HK)盈利恢復速度良好並獲得市場認可。
該行表示,在新業務價值反彈,以及市場或見底的額外增長情況下,中國人壽(02628.HK)及中國太保(02601.HK)仍是該行首選。該行將人保(01339.HK)的目標價由2.9元下調至2.8元,維持其評級為「買入」。該行亦提到,中國平安(02318.HK)新業務價值可見穩定性,但其物業板塊風險仍為不確定因素,目標價57元,評級「買入」。
該行亦將新華保險(01336.HK)目標價由21元下調至18.5元,將其評級由「買入」降至「持有」,主要由於第三季投資環境艱難,對新華保險投資導向經營模式不利;新業務持續遜於同業,加上策略投資者復星出售資產潛在不利因素。(ca/k)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.